Enzalutamide: New Weapon Against Metastatic Prostate Cancer

This F1000 commentary reports on enzalutamide, a novel antiandrogen in patients with metastatic prostate cancer.

Source: Medscape Urology Podcast - January 4, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts